Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3318 of 6351
-
Tiny zaps for fibro pain: new study tests microcurrent therapy
Symptom relief OngoingExplore the use of microcurrent therapy for fibromyalgia patients and evaluate its effect on generalized pain and quality of life. Determine if microcurrent therapy be effectively self-administered by the patient as an adjunct to medical pain management.
Sponsor: Paul Crawford • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Blood protein map may reveal hidden clues in ovarian cancer treatment
Knowledge-focused CompletedThis longitudinal observational study investigates treatment-associated changes in the circulating plasma proteome of patients with ovarian cancer undergoing standard treatment. Although CA125 and HE4 are established biomarkers for monitoring treatment response, they provide only…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New drug candidate targets Hard-to-Treat cancers in early trial
Disease control OngoingThis is a Phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics and efficacy of FDA018-ADC in patients with advanced/metastatic solid tumors.
Phase 1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Hospital opioid treatment study tests best way to help patients
Disease control OngoingThis study is a multi-site, cluster randomized, two group implementation trial comparing a low- versus high-intensity implementation strategy for supporting hospital-based opioid use disorder treatment (HBOT) in community hospital settings where medication for opioid use disorder…
Sponsor: Gavin Bart • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New nerve block technique may cut opioid use after breast surgery
Symptom relief CompletedThis project intends to more thoroughly investigate the direct influence of Pecs blocks in the administration of Exparel, a non-opioid analgesic, in breast reconstruction surgery. The hypothesis is that this analgesic delivery method will significantly reduce negative outcomes su…
Phase 3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Talking therapy shows promise for angry kids
Symptom relief CompletedThis pilot study evaluated whether cognitive behavioral therapy for anger and aggression, added to treatment as usual, was associated with reductions in irritability and suicidal ideation in preteen children with externalizing disorders. Children aged 8 to 12 years who were refer…
Sponsor: Geha Mental Health Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Could a cheap old drug beat blood cancer? lab study launches
Knowledge-focused Recruiting nowThe outlook for patients with haematological malignancies remains challenging. It has been shown in some early cancer studies that a particular drug called Zn-DDC otherwise known as Imuthiol is highly toxic to cancer stem cells. Imuthiol has been intravenously used in clinical tr…
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Can a few therapy sessions ease jaw pain and improve sleep?
Symptom relief CompletedThis clinical study aims to compare the efficacy of two brief psychological interventions: Brief Behavioral Therapy for Insomnia (BBIT) and Physical Self-Regulation or (PSR) delivered over telehealth for the management of chronic musculoskeletal orofacial pain conditions (local m…
Sponsor: Ian Boggero, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New pill shows promise in early trial for Tough-to-Treat cancers
Disease control OngoingThe purpose of this study is to characterize the safety and tolerability of IAG933 in patients with mesothelioma, NF2/LATS1/LATS2 mutated tumors and tumors with functional YAP/TAZ fusions and to identify the maximum tolerated dose and/or recommended dose.
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New program aims to ease the burden of head and neck cancer treatment
Symptom relief OngoingHead and neck cancer accounts for 3% of malignancies in the United States. However, the diagnosis and treatment for head and neck cancer is considered to be debilitating. Not because of its morbidity, but due to the extremely rigorous treatment course which has a profound impact …
Sponsor: Sanford Health • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Blue dye may keep blood pressure up during kidney dialysis
Disease control CompletedHypotension is a common complication of intermittent renal replacement therapy. Methylene blue, an inhibitor of nitric oxide synthesis, has been suggested to improve hemodynamics during renal replacement therapy in ambulatory patients, but evidence is lacking for critically ill p…
Phase 2 • Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can simple tools help cancer survivors live healthier?
Disease control OngoingThis clinical trial studies the effect of four different intervention components "tools" on body weight, nutrition, and physical activity in cancer survivors. Studies indicate that people with a history of cancer whose nutrition and physical activity habits are consistent with th…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for reducing narcolepsy attacks over the long term
Symptom relief CompletedThis study will evaluate the long-term efficacy and safety of AXS-12 in narcoleptic subjects with cataplexy and excessive daytime sleepiness (EDS).
Phase 3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New pain block study aims to help rib fracture patients breathe easier
Symptom relief CompletedRib fractures are seen in more than 50% of patient spresenting with blunt chest trauma and are associated with significant morbidity, long-term disability and mortality . Many of these adverse consequences are a result ofinadequately controlled pain which hinders respiration,lea…
Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo shows promise for tough cancers
Disease control OngoingThis phase I trial tests the safety, side effects and best dose of BAY 1895344 when given together with usual chemotherapy (irinotecan or topotecan) in treating patients with solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant p…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug cocktail targets pancreatic Cancer's defenses before surgery
Disease control OngoingThis proposal will investigate the effect of paricalcitol, hydroxychloroquine, and losartan (PHL) combination of 3 stroma-modifying drugs on pancreatic adenocarcinoma and its stroma.
Early phase 1 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Virtual pain coaching shows promise for breast cancer patients in rural clinics
Symptom relief CompletedThe efficacy of a mobile health (mHealth) behavioral cancer pain intervention designed to decrease pain and disability for breast cancer patients in medically underserved areas has not been investigated. The long-term goal of this work is to use mHealth technologies to facilitate…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Brain training for autism: can therapy rewire learning in teens?
Knowledge-focused OngoingThis project explores the association between learning and cognitive flexibility by testing whether a cognitive behavioral intervention designed to improve flexibility in ASD changes learning and associated neural activation using model-based functional magnetic resonance imaging…
Sponsor: Children's National Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New hope for depressed pregnant smokers: mood program aims to help quit for good
Symptom relief OngoingThis study evaluates a mood management and health and wellness smoking cessation intervention for depressed pregnant smokers during and after birth. This study may help pregnant smokers who are experiencing depression quit smoking and stay smoke-free after their babies are born.
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Scientists try to personalize heated chemo for stomach cancers
Knowledge-focused Recruiting nowBackground: Cytoreductive surgery (CRS) removes tumors in the abdomen. HIPEC is hyperthermic (heated) chemotherapy that washes the inside of the abdomen. CRS with HIPEC may help people with peritoneal carcinomatosis. These are tumors that have spread to the lining of the abdomen…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC